Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism NLRP3 inhibitors(NACHT, LRR and PYD domains-containing protein 3 inhibitors), SMAD2 inhibitors(Mothers against decapentaplegic homolog 2 inhibitors), SMAD3 inhibitors(Mothers against decapentaplegic homolog 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Asthma | Preclinical | China | 01 Nov 2025 |





